Cargando…
Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the US, UK, or France who treated their cats with transdermal fluralaner
BACKGROUND: Fluralaner (Bravecto(®)) is an isoxazoline class compound that is the only topically applied systemic ectoparasiticide approved for dosing at up to 12-week intervals for flea and tick control in cats. AIM: To describe veterinarian recommendations for ectoparasiticide medications used in...
Autores principales: | Lavan, Robert Philip, Armstrong, Robert, Newbury, Hannah, Normile, Dorothy, Hubinois, Celine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of Veterinary Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541722/ https://www.ncbi.nlm.nih.gov/pubmed/34722211 http://dx.doi.org/10.5455/OVJ.2021.v11.i3.19 |
Ejemplares similares
-
Flea and tick treatment satisfaction, preference, and adherence of US cat owners prescribed topical fluralaner (Bravecto(®) Topical Solution for Cats)
por: Lavan, Robert, et al.
Publicado: (2021) -
Flea and tick treatment satisfaction, preference, and adherence of dog owners in the United States, United Kingdom, and Australia who treated their dog with fluralaner
por: Lavan, Robert, et al.
Publicado: (2020) -
Dog owner flea/tick medication purchases in the USA
por: Lavan, Robert, et al.
Publicado: (2018) -
Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA
por: Lavan, Robert, et al.
Publicado: (2020) -
Open field study on the efficacy of fluralaner topical solution for long-term control of flea bite allergy dermatitis in client owned cats in Ile-de-France region
por: Briand, Amaury, et al.
Publicado: (2019)